Cancer Detection and Diagnosis Research in South Carolina
Cancer Detection and Diagnosis Research (93.394) awarded $11.1 million to recipients in South Carolina in 14 grants from fiscal 2021 to 2025, 0.4% of the program's national total. The Medical University of South Carolina received the most, $7.8 million.
- Awarded in South Carolina$11.1 million
- Awards14
- Share of the program0.4%
- Rank among states31st of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 5 | $1.5 million |
| FY 2022 | 9 | $2.9 million |
| FY 2023 | 8 | $2.4 million |
| FY 2024 | 8 | $2.3 million |
| FY 2025 | 5 | $2.0 million |
Recipients in South Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Medical University of South Carolina | Colleges and universities | 8 | $7.8 million |
| University of South Carolina | Colleges and universities | 5 | $2.9 million |
| Glycopath, LLC | Small businesses | 1 | $428,443 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to South Carolina?
$11.1 million from fiscal 2021 to 2025, across 14 awards. South Carolina ranks 31st of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in South Carolina?
The largest recipient is The Medical University of South Carolina, with $7.8 million in 8 awards. Next are University of South Carolina and Glycopath, LLC.
Can organizations in South Carolina apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in South Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start